Inclusion Criteria:  Must have stable renal function defined as a less than (<) 20 percent (%) change in serum creatinine concentrations between screening and Day -1 Concomitant medications should be stable for the previous 1 month and throughout the duration of the study Women, except for postmenopausal women, must have a negative highly sensitive serum (beta-human chorionic gonadotropin [beta-hCG]) at screening and urine (beta-hCG) pregnancy test on Day -1 Must sign an informed consent form (ICF) indicating they understand the purpose of, and procedures required for the study and are willing to participate in the study Participants with kidney disease without dialysis using benzodiazepines, tricyclic antidepressants, and prescription opiates with a positive urine test for drugs prescribed by their physician may be included following prior discussion with the sponsor  Exclusion Criteria:  Have kidney disease requiring dialysis Renal transplants, systemic lupus erythematosus, or participant with malignancy Known allergies, hypersensitivity, or intolerance to JNJ-73763989 or its excipients Received an experimental drug (including investigational vaccines) or used an experimental medical device within 1 month or within a period less than 10 times the drug's half-life, whichever is longer, before the administration of the study drug is scheduled Preplanned surgery or procedures that would interfere with the conduct of the study